First name
John
Last name
Kopsidas

Title

Epidemiology of infections and antimicrobial use in Greek Neonatal Units.

Year of Publication

2018

Number of Pages

Date Published

2018 Jun 28

ISSN Number

1468-2052

Abstract

<p><strong>OBJECTIVE: </strong>To describe the epidemiology of neonatal infections and of antimicrobial use in Greek Neonatal Units (NNUs) in order to develop national, evidence-based guidelines on empiric antimicrobial use for neonatal sepsis in Greece.</p>

<p><strong>DESIGN: </strong>Retrospective analysis of prospectively collected infection surveillance data from 2012 to 2015, together with a Point Prevalence Survey (PPS) on antimicrobial use and the collection of data on local empiric antimicrobial policies.</p>

<p><strong>SETTING: </strong>16 NNUs in Greece participating in the neonIN infection surveillance network PATIENTS: Newborns in participating NNUs who had a positive blood, cerebrospinal fluid or urine culture and were treated with at least 5 days of antibiotics.</p>

<p><strong>RESULTS: </strong>459 episodes were recorded in 418 infants. The overall incidence of infection was 50/1000 NNU-admissions. The majority of episodes were late-onset sepsis (LOS) (413, 90%). (80%) were the most common Gram-positive organisms causing LOS and spp (39%) the most common Gram-negative. Nearly half (45%) of the spp were resistant to at least one aminoglycoside. The PPS revealed that 196 of 484 (40%) neonates were on antimicrobials. The survey revealed wide variation in empiric antimicrobial policies for LOS.</p>

<p><strong>CONCLUSIONS: </strong>This is the largest collection of data on the epidemiology of neonatal infections in Greece and on neonatal antimicrobial use. It provides the background for the development of national evidence-based guidelines. Continuous surveillance, the introduction of antimicrobial stewardship interventions and evidence-based guidelines are urgently required.</p>

DOI

10.1136/archdischild-2018-315024

Alternate Title

Arch. Dis. Child. Fetal Neonatal Ed.

PMID

29954881
Inner Banner
Publication Image
Inner Banner
Publication Image

Title

Variation in paediatric hospital antibiotic guidelines in Europe.

Year of Publication

2016

Number of Pages

72-6

Date Published

2016 Jan

ISSN Number

1468-2044

Abstract

<p><strong>OBJECTIVE: </strong>To assess the availability and source of guidelines for common infections in European paediatric hospitals and determine their content and characteristics.</p>

<p><strong>DESIGN: </strong>Participating hospitals completed an online questionnaire on the availability and characteristics of antibiotic prescribing guidelines and on empirical antibiotic treatment including duration of therapy for 5 common infection syndromes: respiratory tract, urinary tract, skin and soft tissue, osteoarticular and sepsis in neonates and children.</p>

<p><strong>RESULTS: </strong>84 hospitals from 19 European countries participated in the survey of which 74 confirmed the existence of guidelines. Complete guidelines (existing guidelines for all requested infection syndromes) were reported by 20% of hospitals and the majority (71%) used a range of different sources. Guidelines most commonly available were those for urinary tract infection (UTI) (74%), neonatal sepsis (71%) and sepsis in children (65%). Penicillin and amoxicillin were the antibiotics most commonly recommended for respiratory tract infections (RTIs) (up to 76%), cephalosporin for UTI (up to 50%) and for skin and soft tissue infection (SSTI) and bone infection (20% and 30%, respectively). Antistaphylococcal penicillins were recommended for SSTIs and bone infections in 43% and 36%, respectively. Recommendations for neonatal sepsis included 20 different antibiotic combinations. Duration of therapy guidelines was mostly available for RTI and UTI (82%). A third of hospitals with guidelines for sepsis provided recommendations for length of therapy.</p>

<p><strong>CONCLUSIONS: </strong>Comprehensive antibiotic guideline recommendations are generally lacking from European paediatric hospitals. We documented multiple antibiotics and combinations for most infections. Considerable improvement in the quality of guidelines and their evidence base is required, linking empirical therapy to resistance rates.</p>

DOI

10.1136/archdischild-2015-308255

Alternate Title

Arch. Dis. Child.

PMID

26416900
Inner Banner
Publication Image
Inner Banner
Publication Image

Title

Antibiotic prescribing and expenditures in outpatient paediatrics in Greece, 2010-13.

Year of Publication

2015

Number of Pages

2405-8

Date Published

08/2015

ISSN Number

1460-2091

Abstract

<p><strong>OBJECTIVES: </strong>The objectives of this study were to provide a nationally representative analysis of antibiotic prescribing in outpatient paediatrics and to assess overall and class-specific antibiotic costs in Greece.</p>

<p><strong>METHODS: </strong>Data on antibiotic prescriptions for patients aged ≤19 years old between July 2010 and June 2013 in Greece were extracted from the IMS Health Xponent database. Antibiotics were grouped into narrow- and broad-spectrum agents. The number of prescribed antibiotics and census denominators were used to calculate prescribing rates. The total costs associated with prescribed antibiotics were calculated.</p>

<p><strong>RESULTS: </strong>More than 7 million antibiotics were prescribed during the study period, with an annual rate of 1100 antibiotics/1000 persons. Prescribing rates were higher among children aged &lt;10 years old. Acute respiratory tract infections (ARTIs) accounted for 80% of prescribed antibiotics, with acute otitis media (22.3%), acute tonsillitis (19.5%) and acute bronchitis/bronchiolitis (13.9%) being the most common clinical diagnoses. Cephalosporins (32.9%), penicillins (32.3%) and macrolides (32.1%) were the most commonly prescribed antibiotic classes. The majority (90.4%) of antibiotics were broad spectrum. Antibiotic expenditures totalled ∼€50 million.</p>

<p><strong>CONCLUSIONS: </strong>Broad-spectrum antibiotic prescribing is common in outpatient paediatric patients. These data provide important targets to inform the development of an outpatient antimicrobial stewardship programme targeting specific practices, providers and conditions.</p>

DOI

10.1093/jac/dkv091

Alternate Title

J. Antimicrob. Chemother.

PMID

25881618
Inner Banner
Publication Image
Inner Banner
Publication Image